Home

Lab Interests:

Why do we study Chaperones?

Mechanism of In Vivo Protein Folding

Function and Mechanism of the Chaperonin TRiC

Coupling Between Chaperones and the Degradation Machinery

Regulation of the Tumor Suppressor Protein VHL

 

MECHANISMS OF IN VIVO PROTEIN FOLDING

In contrast to in vitro refolding experiments, folding in the cell must be accomplished in the context of the vectorial synthesis of polypeptide chains on ribosomes. In principle, the N-terminal portion of the polypeptide could fold spontaneously as it emerges from the ribosome. On the other hand, the cooperative nature of the interactions that stabilize folded structures requires a complete folding domain (100-200 amino acids) to be available for productive folding. Given the high density of folding protein molecules emerging from polysomes, this would imply that the growing polypeptide has to be effectively prevented from misfolding and aggregating, until a chain length suitable for productive folding has been synthesized. The present project proposes to combines biochemical and cell biological approaches to investigate the folding of newly synthesized proteins. We have developed two experimental approaches that will yield complementary information. The first approach relies on the biochemical and biophysical analysis of newly synthesized proteins using in cell-free translation lysates derived from eukaryotic cells. The second approach examines the interaction of molecular chaperones with newly translated polypeptides in the cytosol of intact mammalian cells. Using the cell-free translation system we have uncovered substantial differences between the mechanisms of chaperone-mediated folding of denatured and newly translated proteins . These biochemical experiments indicated that the successful folding of newly-translated proteins is mediated by a highly organized chaperone machinery. For instance, the pathway that folds firefly luciferase combines two distinct principles of chaperone action, namely the Hsp70/Hsp40 proteins, that act by stabilizing extended polypeptides, and the chaperonin TRiC, which by virtue of its ring-like structure creates an environment that is favorable for polypeptide folding. Furthermore, our in vivo experiments have demonstrated that the cellular chaperone machinery is coupled to translation to create a protected environment where newly synthesized proteins fold.

The association of chaperones with nascent polypeptides raises many questions concerning the biochemistry and cell biology of protein folding. The goals of our research are:

-To understand the mechanism of chaperone-mediated folding during translation.

-To define which subsets of cellular proteins require chaperone assistance to fold in vivo.

-To uncover novel components of the cellular chaperone machinery and examine the regulation of protein folding in mammalian cells.

To this end, we are currently developing new strategies to study the interactions between newly translated polypeptides and components of the folding machinery. In order to gain mechanistic insights we are using biochemical and biophysical approaches to dissect folding following translation in cell-free systems. On the other hand, we are studying the process of protein folding in intact mammalian cells. By following the folding kinetics and chaperone interactions of newly translated polypeptides in vivo we expect to understand how this complex cellular machinery determines the fate of proteins in the cell.

1) Biochemical Analysis of Polypeptide Folding During Translation.
To study mechanistic and regulatory aspects of folding during translation, we are exploiting the in vitro translation system we previously developed in combination with molecular tools and reagents that arise from previous biophysical, structural and genetic studies. A particularly advantageous approach is the incorporation of photoactivatable crosslinkers and fluorescent probes into the nascent chains by addition of chemically modified aminoacyl-tRNAs to the translation reactions . In this method, lysyl-tRNA's are modified by the addition of a photoactivatable azido crosslinker moiety in the epsilon-amino group (N3-Lys-tRNA) (Figure 1 A).

The presence of photoactivatable crosslinkers allows the identification of novel proteins that bind to nascent chains (Figure 1 B), while the incorporation of fluorescent probes facilitates the analysis of folding intermediates produced during translation. This system constitutes a powerful tool for the biochemical dissection of the folding machinery, particularly when combined with other reagents such as temperature-sensitive chaperone mutants and truncated mRNAs that generate nascent chains of defined length. Since this methodology can also be used to incorporate fluorescent probes into nascent chains, it provides the means to analyze the folding intermediates that are generated during translation, including the formation of folded sub-structures and the effect of binding to chaperones. We are currently exploring the potential of this methodology using as model substrates the proteins actin and luciferase. We have detected crosslinking of luciferase and actin nascent chains to several chaperone proteins in the lysate including Hsc70 and TRiC (Figure 1 C for Hsc70).

Using these biochemical approaches we expect to identify the necessary components that mediate folding and recruit molecular chaperones to the nascent chains. For example, by using the binding of the nascent chain to a specific chaperone as an assay, it will be possible to identify the factors necessary to recruit chaperones into a complex that can fold nascent chains. This approach may identify additional components of the cellular folding machinery, including factors that catalyze the covalent and non-covalent modification of newly-synthesized proteins, such as folding catalysts and enzymes for the attachment of prosthetic groups. Our ultimate goal will be the in vitro reconstitution of the translation-folding machinery using purified components.

2) Protein Folding in the cell.
As stated above, the main goal of our studies is to understand how proteins fold in the cell.

A very important question concerns the overall contribution of chaperones to folding in vivo . In principle, it is conceivable that distinct chaperone pathways exist to regulate the diverse fates of polypeptides in the cytosol. To investigate this problem we have developed an experimental system using cultured mammalian cells capable of inducibly expressing dominant negative chaperone-mutants. Recently, we have used this system to investigate the processivity of cellular folding. To this end, we overexpressed in mammalian cells a bacterial chaperonin "trap", that irreversibly captures unfolded polypeptides. This "trap" did not interrupt the productive folding pathway and was unable to bind newly translated polypeptides which bound instead to endogenous chaperones. This study indicated that folding in mammalian cells occurs without the release of non-native folding intermediates into the bulk cytosol, and established that de novo protein folding occurs in a protected environment created by a highly processive chaperone machinery. It will be of great importance to determine how the processivity is established. One contributing factor is probably the coupling of the folding machinery to translation. To gain understanding into this question we are planning to identify the cellular factors that bind to ribosome-bound nascent chains.


 

The study of folding in mammalian cells has also allowed us to address a number of questions regarding the most characterized cytosolic chaperone system, namely Hsc70 and TRiC. For instance, using intact mammalian cells we determined the contribution of the major chaperone systems in the cytosol to de novo folding. To this end we examined what fraction of newly translated cellular proteins transit through these chaperones. Our approach involves pulse-chase protocols followed by the stabilization and analysis of the complexes between folding substrates and endogenous chaperones. We found that a large fraction of newly translated polypeptides associate transiently with the molecular chaperones Hsc70 and the chaperonin TRiC/CCT during their biogenesis (Figure 2). The substrate repertoire observed for Hsc70 and TRiC is not identical: Hsc70 interacts with a wide spectrum of polypeptides larger than 20 kDa, while TRiC associates with a diverse set of proteins between 30-60 kDa. We observed that approximately 15-20% of the total labeled proteins bound transiently to Hsc70 and ~9-15% associated with TRiC. The identification of endogenous chaperone-substrates will allow us to define the structural features that underlie the requirement for a specific chaperone system in the cell. Our experiments have also indicated that a significant portion of newly synthesized polypeptides (~65%) appear to reach the native state without the assistance of Hsc70 or TRiC (Figure 2). It is conceivable that a fraction of these polypeptides folds in a chaperone-independent manner. However, novel uncharacterized chaperone systems may be responsible for folding specific subsets of cytosolic proteins. We hope to identify these novel systems by combining these in vivo studies with biochemical approaches.

Developing these experimental systems will allow us to investigate other aspects of protein folding. The basic chaperone machinery may be used to assemble more complex macromolecular structures, such as amyloid deposits and viral particles